NINGBO INNO PHARMCHEM CO.,LTD. is a trusted source for high-quality pharmaceutical ingredients and research chemicals. Among these, Aztreonam (CAS 78110-38-0) holds significant importance due to its unique properties and diverse applications in pharmaceutical research and development.

Aztreonam is a synthetic monocyclic beta-lactam antibiotic with a highly specific action against Gram-negative bacteria. Its primary pharmaceutical application in research revolves around its potent mechanism of inhibiting bacterial cell wall synthesis. By selectively targeting Penicillin-Binding Protein 3 (PBP3), Aztreonam disrupts the formation of a stable peptidoglycan layer, leading to bacterial lysis. This specific mode of action makes it an ideal compound for studying the efficacy of different antibiotic classes and the development of novel antimicrobial agents.

Researchers utilize Aztreonam in various contexts. It is a key component in studies investigating antibiotic resistance, particularly the mechanisms by which bacteria evade beta-lactam antibiotics. Its stability against many beta-lactamases allows for detailed analysis of enzyme function and bacterial adaptation strategies. Furthermore, Aztreonam is used in pharmacological studies to understand drug delivery, pharmacokinetics, and potential synergistic effects when combined with other agents.

The ability to purchase Aztreonam of high purity from reputable suppliers like NINGBO INNO PHARMCHEM CO.,LTD. is crucial for ensuring the reliability of research outcomes. The price of Aztreonam reflects its complex manufacturing process and its vital role in advancing pharmaceutical science. For institutions engaged in drug discovery and development, sourcing effective compounds like Aztreonam is a strategic necessity.

In summary, Aztreonam's specific antibacterial activity and its utility in studying resistance mechanisms and drug action make it an indispensable tool in pharmaceutical research. NINGBO INNO PHARMCHEM CO.,LTD. is proud to support this scientific endeavor by providing access to this critical compound.